William D. Waddill Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William D. Waddill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William D. Waddill. William D. Waddill is Director in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) and SVP & Chief Financial Officer in OncoMed Pharmaceuticals Inc ($OMED) and Director in Protagonist Therapeutics, Inc ($PTGX) and SR. VP & CFO in Calithera Biosciences, Inc. ($CALA).
Latest Insider Trading Transactions of William D. Waddill
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARWR, CALA, OMED, PTGX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2021 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 35.23 | 18,000 | 634,140 | 18,000 | |
Dec 11 2020 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Sell | S | 73.10 | 1,800 | 131,580 | 25,000 | 26.8 K to 25 K (-6.72 %) |
Dec 11 2020 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Sell | S | 68.50 | 1,200 | 82,200 | 26,800 | 28 K to 26.8 K (-4.29 %) |
May 29 2020 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
May 13 2020 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Sell | S | 36.54 | 26,000 | 950,040 | 28,000 | 54 K to 28 K (-48.15 %) |
Jun 11 2019 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
Jan 11 2019 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Sell | S | 14.77 | 8,500 | 125,545 | 46,500 | 55 K to 46.5 K (-15.45 %) |
Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Grant | A | 0.00 | 30,000 | 0 | 55,000 | 25 K to 55 K (+120.00 %) |
Jun 12 2018 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
Jan 03 2018 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
May 26 2017 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 8.59 | 12,000 | 103,080 | 12,000 | |
Dec 01 2016 | CALA | Calithera Bioscien ... | Waddill William D. | SR. VP & CFO | Option Exercise | A | 3.35 | 75,000 | 251,250 | 75,000 | |
Oct 03 2016 | CALA | Calithera Bioscien ... | Waddill William D. | SR. VP & CFO | Sell | J | 0.00 | 17,485 | 0 | 17,485 | 35 K to 17.5 K (-50.00 %) |
Sep 15 2016 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 12.88 | 24,000 | 309,120 | 24,000 | |
Jan 21 2016 | CALA | Calithera Bioscien ... | Waddill William D. | SR. VP & CFO | Option Exercise | A | 4.71 | 70,000 | 329,700 | 70,000 | |
Jul 16 2015 | CALA | Calithera Bioscien ... | Waddill William D. | SR. VP & CFO | Option Exercise | M | 2.64 | 13,125 | 34,650 | 61,880 | |
Jul 16 2015 | CALA | Calithera Bioscien ... | Waddill William D. | SR. VP & CFO | Buy | M | 2.64 | 13,125 | 34,650 | 15,625 | 2.5 K to 15.6 K (+525.00 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | Waddill William D. | SVP & Chief Financi ... | Option Exercise | C | 0.00 | 5,159 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | Waddill William D. | SVP & Chief Financi ... | Buy | C | 0.00 | 5,159 | 0 | 29,758 | 24.6 K to 29.8 K (+20.97 %) |
Jul 19 2013 | OMED | OncoMed Pharmaceut ... | Waddill William D. | SVP & Chief Financi ... | Option Exercise | A | 17.00 | 14,000 | 238,000 | 14,000 |
Page: 1